R. Ryanne Wu

1.7k total citations
33 papers, 532 citations indexed

About

R. Ryanne Wu is a scholar working on Oncology, Genetics and General Health Professions. According to data from OpenAlex, R. Ryanne Wu has authored 33 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 15 papers in Genetics and 10 papers in General Health Professions. Recurrent topics in R. Ryanne Wu's work include BRCA gene mutations in cancer (14 papers), Global Cancer Incidence and Screening (10 papers) and Colorectal Cancer Screening and Detection (9 papers). R. Ryanne Wu is often cited by papers focused on BRCA gene mutations in cancer (14 papers), Global Cancer Incidence and Screening (10 papers) and Colorectal Cancer Screening and Detection (9 papers). R. Ryanne Wu collaborates with scholars based in United States, Singapore and Australia. R. Ryanne Wu's co-authors include Lori A. Orlando, Geoffrey S. Ginsburg, Elizabeth R. Hauser, Adam H. Buchanan, Vincent C. Henrich, Tiffany Himmel, Karen Powell, Rachel A. Myers, Rebecca Slack and John L. Marshall and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of General Internal Medicine.

In The Last Decade

R. Ryanne Wu

31 papers receiving 522 citations

Peers

R. Ryanne Wu

GENET

ONCOL

PHEOH

GHP

PFM

Juan L. Rodriguez United States

Christine B. Weldon United States

Debra Duquette United States

Katherine Kolor United States

Julia R. Trosman United States

Courtney D. Storm United States

C. Klabunde United States

Sunita Miles United States

Ruth Heisey Canada

Cecilia R. DeGraffinreid United States

Juan L. Rodriguez United States

R. Ryanne Wu

192 ×0.8

GENET

172 ×1.2

ONCOL

103 ×0.9

PHEOH

72 ×0.6

GHP

36 ×0.5

PFM

Citations per year, relative to R. Ryanne Wu R. Ryanne Wu (= 1×) peers Juan L. Rodriguez

Countries citing papers authored by R. Ryanne Wu

Since Specialization

Citations

This map shows the geographic impact of R. Ryanne Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Ryanne Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Ryanne Wu more than expected).

Fields of papers citing papers by R. Ryanne Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Ryanne Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Ryanne Wu. The network helps show where R. Ryanne Wu may publish in the future.

Co-authorship network of co-authors of R. Ryanne Wu

This figure shows the co-authorship network connecting the top 25 collaborators of R. Ryanne Wu. A scholar is included among the top collaborators of R. Ryanne Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Ryanne Wu. R. Ryanne Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sperber, Nina, Megan C. Roberts, Deborah Cragun, et al.. (2024). Pharmacogenetic testing in primary care could bolster depression treatment: A value proposition. Clinical and Translational Science. 17(6). e13837–e13837. 1 indexed citations

Silva, Abigail, Deepak Voora, R. Ryanne Wu, et al.. (2024). Trends in and predictors of patient pharmacogenomic test uptake in a national health care system. Genetics in Medicine. 27(3). 101308–101308. 2 indexed citations

Mittendorf, Kathleen F., Harris T. Bland, Gillian W. Hooker, et al.. (2024). Family history and cancer risk study (FOREST): A clinical trial assessing electronic patient-directed family history input for identifying patients at risk of hereditary cancer. Contemporary Clinical Trials. 148. 107714–107714.

Gavin, Kara L., Esra Alagöz, Nina Sperber, et al.. (2023). Patient Perspectives of Barriers and Facilitators for the Uptake of Pharmacogenomic Testing in Veterans Affairs’ Pharmacogenomic Testing for the Veterans (PHASER) Program. Journal of Personalized Medicine. 13(9). 1367–1367. 3 indexed citations

Voils, Corrine I., Cynthia J. Coffman, R. Ryanne Wu, et al.. (2022). A Cluster Randomized Trial of a Family Health History Platform to Identify and Manage Patients at Increased Risk for Colorectal Cancer. Journal of General Internal Medicine. 38(6). 1375–1383. 4 indexed citations

Wu, R. Ryanne, Rachel A. Myers, Joan Neuner, et al.. (2022). Implementation-effectiveness trial of systematic family health history based risk assessment and impact on clinical disease prevention and surveillance activities. BMC Health Services Research. 22(1). 1486–1486. 4 indexed citations

Wu, R. Ryanne, Rachel A. Myers, Geoffrey S. Ginsburg, et al.. (2021). Clinical implementation of an oncology‐specific family health history risk assessment tool. Hereditary Cancer in Clinical Practice. 19(1). 20–20. 1 indexed citations

Bylstra, Yasmin, Weng Khong Lim, R. Ryanne Wu, et al.. (2021). Correction to: Family history assessment significantly enhances delivery of precision medicine in the genomics era. Genome Medicine. 13(1). 109–109. 1 indexed citations

Wu, R. Ryanne, Rehena Sultana, Yasmin Bylstra, et al.. (2020). Evaluation of family health history collection methods impact on data and risk assessment outcomes. Preventive Medicine Reports. 18. 101072–101072. 3 indexed citations

10.

Goldstein, Karen M., Deborah A. Fisher, R. Ryanne Wu, et al.. (2019). An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial. Trials. 20(1). 576–576. 7 indexed citations

11.

Wu, R. Ryanne, Rachel A. Myers, Nina Sperber, et al.. (2018). Implementation, adoption, and utility of family health history risk assessment in diverse care settings: evaluating implementation processes and impact with an implementation framework. Genetics in Medicine. 21(2). 331–338. 24 indexed citations

12.

Orlando, Lori A., Nina Sperber, Corrine I. Voils, et al.. (2017). Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network’s Common Measures Working Group. Genetics in Medicine. 20(6). 655–663. 49 indexed citations

13.

Orlando, Lori A., R. Ryanne Wu, Rachel A. Myers, et al.. (2016). Clinical utility of a Web-enabled risk-assessment and clinical decision support program. Genetics in Medicine. 18(10). 1020–1028. 29 indexed citations

14.

Wu, R. Ryanne, Rachel A. Myers, Elizabeth R. Hauser, et al.. (2016). Impact of Genetic Testing and Family Health History Based Risk Counseling on Behavior Change and Cognitive Precursors for Type 2 Diabetes. Journal of Genetic Counseling. 26(1). 133–140. 22 indexed citations

15.

Wu, R. Ryanne, Rachel A. Myers, Catherine A. McCarty, et al.. (2015). Protocol for the “Implementation, adoption, and utility of family history in diverse care settings” study. Implementation Science. 10(1). 163–163. 17 indexed citations

16.

Orlando, Lori A., R. Ryanne Wu, Christopher A. Beadles, et al.. (2014). Implementing family health history risk stratification in primary care: Impact of guideline criteria on populations and resource demand. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 166(1). 24–33. 37 indexed citations

17.

Beadles, Christopher A., R. Ryanne Wu, Tiffany Himmel, et al.. (2014). Providing patient education: impact on quantity and quality of family health history collection. Familial Cancer. 13(2). 325–332. 23 indexed citations

18.

Wu, R. Ryanne, Linda Kinsinger, Dawn Provenzale, et al.. (2014). Implementation of New Clinical Programs in the VHA Healthcare System: The Importance of Early Collaboration Between Clinical Leadership and Research. Journal of General Internal Medicine. 29(S4). 825–830. 13 indexed citations

19.

Wu, R. Ryanne, Tiffany Himmel, Adam H. Buchanan, et al.. (2014). Quality of family history collection with use of a patient facing family history assessment tool. BMC Family Practice. 15(1). 31–31. 34 indexed citations

20.

Wu, R. Ryanne, et al.. (2009). Evaluation of Hypertension as a Marker of Bevacizumab Efficacy. Journal of Gastrointestinal Cancer. 40(3-4). 101–108. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact